Cargando…
Progressive Pulmonary Fibrosis After Non-Critical COVID-19: A Case Report
Patient: Male, 42-year-old Final Diagnosis: Pulmonary fibrosis Symptoms: Dyspnea Medication:— Clinical Procedure: — Specialty: General and Internal Medicine • Pulmonology OBJECTIVE: Unusual clinical course BACKGROUND: The COVID-19 global pandemic is ongoing, and despite vaccination efforts, SARS-CoV...
Autores principales: | Doane, Jedediah J., Hirsch, Kellen S., Baldwin, Justine O., Wurfel, Mark M., Pipavath, Sudhakar N., West, T. Eoin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650386/ https://www.ncbi.nlm.nih.gov/pubmed/34848676 http://dx.doi.org/10.12659/AJCR.933458 |
Ejemplares similares
-
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
por: Bhatraju, Pavan K., et al.
Publicado: (2020) -
Comparison of Clinical Features and Outcomes in Critically Ill Patients Hospitalized with COVID-19 versus Influenza
por: Cobb, Natalie L., et al.
Publicado: (2021) -
MicroRNAs as potential targets for progressive pulmonary fibrosis
por: Rajasekaran, Subbiah, et al.
Publicado: (2015) -
Imaging of Lung Transplantation
por: Ahuja, Jitesh, et al.
Publicado: (2018) -
Plasma Soluble CD14 Subtype Levels Are Associated With Clinical Outcomes in Critically Ill Subjects With Coronavirus Disease 2019
por: Mabrey, F. Linzee, et al.
Publicado: (2021)